L-arginine suppresses lipopolysaccharide-induced expression of RANTES in glomeruli

Journal of the American Society of Nephrology

Volumn 9, Issue 2, 1998, Pages 203-210

  Haberstroh, Uwe ^a   Stilo, Karin ^a   Pocock, Johanna ^a   Wolf, Gunter ^a   Helmchen, Udo ^b   Wenzel, Ulrich ^a   Zahner, Gunther ^a   Stahl, Rolf A K ^a   Thaiss, Friedrich ^a,b  

^a Division of Nephrology and Osteology   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CHEMOKINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PROTEIN; RANTES;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

EID: 0031890543     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Morrison DC, Ryan JL: Endotoxins and disease mechanisms. Annu Rev Med 38: 417-432, 1987
2. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zähringer U, Seydel U, DiPadova F, Schreier M, Brade H: Bacterial endotoxin: Molecular relationship of structure to activity and function. FASEB J 8: 217-225, 1994
3. Cybulsky MI, Chan MKW, Movat HZ: Acute inflammation and micro-thrombosis induced by endotoxin, interleukin-1. and tumor necrosis factor and their implication in gram-negative infection. Lab Invest 58: 365-378, 1988
4. Bertani T, Abbate M, Zoja C, Corna D, Remuzzi G: Sequence of glomerular changes in experimental endotoxemia: A possible model of hemolytic uremic syndrome. Nephron 53: 330-337, 1989
5. Fouqueray B, Philippe C, Herbelin A, Perez J, Ardaillou R, Baud L: Cytokine formation within rat glomeruli during experimental endotoxemia. J Am Soc Nephrol 3: 1783-1791, 1993
6. Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P, Remuzzi G: Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 134: 419-430, 1989
7. Schall TJ, Bacon KB: Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6: 865-873, 1994
8. Banas B, Wenzel U, Stahl RAK, Schlöndorff D: Role of chemokines in glomerular disease. Kidney Blood Press Res 19: 270-280, 1996
9. Brown Z, Robson RL, Westwick J: Regulation and expression of chemokines: Potential role in glomerulonephritis. J Leukocyte Biol 59: 75-80, 1996
10. Schlöndorff D, Nelson PJ, Luckow B, Banas B: Chemokines and kidney. Kidney Int 51: 610-621, 1997
11. Stahl RAK, Thaiss F, Disser M, Helmchen U, Hora K, Schlöndorff D: Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 44: 1036-1047, 1993
12. Wu X, Wittwer AJ, Carr LS, Crippes BA, DeLarco JE, Lefkowith JB: Cytokine-induced neutrophil chemoattractant mediates neutrophil influx in immune complex glomerulonephritis. J Clin Invest 94: 337-344, 1994
13. Tang WW, Yin S, Wittwer AJ, Qi M: Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis. Am J Physiol 269: F323-F330, 1995
14. Wada T, Yokoyama H, Furuichi K, Kobayashi KI, Harada K, Naruto M, Su SB, Akiyama M, Mukaida N, Matsushima K: Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J 10: 1418-1425, 1996
15. Wenzel U, Schneider A, Valente AJ, Abboud HE, Thaiss F, Stahl RAK: Monocyte chemoattractant protein-1 mediates monocyte/ macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 51: 770-776, 1997
16. Wink DA, Hanbauer I, Krishna MC, DeGraff W. Gamson J, Mitchell JB: Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 90: 9813-9817, 1993
17. Florquin S, Amraoui Z, Dubois C, Decuyper J, Goldman M: The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med 180: 1153-1158, 1994
18. Shultz P, Raij L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 90: 1718-1725, 1992
19. Thaiss F, Germann PJ, Kudelka S, Schoeppe W, Helmchen U, Stahl RAK: The effect of thromboxane synthesis inhibition on renal function in a model of membranous nephropathy. Kidney Int 35: 76-83, 1989
20. Heeger P, Wolf G, Meyer C, Sun MJ, O'Farrell SC, Krensky AM. Neilson EG: Isolation and characterization of cDNA from renal tubular epithelium encoding murine RANTES. Kidney Int 41: 220-225, 1992
21. Lowenstein CI, Glatt CS, Brendt DS, Snyder SH: Cloned and expressed nitric oxide synthase contrasts with brain enzyme. Proc Natl Acad Sci USA 89: 6711-6715, 1992
22. Wenzel UO, Fouqueray B, Grandaliano G, Karamitsos C, Kim YS, Valente AJ, Abboud HE: Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. Circ Res 77: 503-509, 1995
23. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, Stahl RAK: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: Role of the angiotensin type 2 receptor. J Clin Invest 100: 1047-1058, 1997
24. Wolf G, Aberle S, Thaiss F, Nelson PJ, Krensky AM, Neilson EG, Stahl RAK: TNFa induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int 44: 795-804, 1993
25. Mühl H, Pfeilschifter J: Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1β-stimulated rat mesangial cells. J Clin Invest 95: 1941-1946, 1995
26. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stocelt JC: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259: H1038-H1043, 1990
27. Stoclet JC, Fleming I, Gray G, Julou-Schaeffer G, Schneider F, Schott C, Schott CH, Parratt JR: Nitric oxide and endotoxemia. Circulation 87[Suppl V]: V77-V80, 1993
28. Kelly RA, Balligand JL, Smith TW: Nitric oxide and cardiac function. Circ Res 79: 363-380, 1996
29. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R: Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76: 980-986, 1995
30. Ikeda M, Ikeda U, Takahashi M, Shimada K, Minota S, Kano S: Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells. J Am Soc Nephrol 7: 2213-2218, 1996
31. Studer RK, DeRubertis FR, Craven PA: Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor β, and fibronectin synthesis induced by thromboxane. J Am Soc Nephrol 7: 999-1005, 1996
32. DeCaterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK: Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60-68, 1996
33. Kahn BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM: Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA 93: 9114-9119, 1996
34. Lamas S, Michel T, Brenner BM, Marsden PA: Nitric oxide synthesis in endothelial cells: Evidence for a pathway inducible by TNF-a. Am J Physiol 261: C634-C641, 1991
35. Reyes AA, Karl IE, Klahr S: Role of arginine in health and in renal disease. Am J Physiol 267: F331-F346, 1994
36. Klahr S, Morrissey J: Renal disease: The two faces of nitric oxide. Lab Invest 72: 1-3, 1995
37. Reyes AA, Karl IE, Kissane J, Klahr S: L-Arginine administration prevents glomerular hyperfiltration and decreases protein-uria in diabetic rats. J Am Soc Nephrol 4: 1039-1045, 1993
38. Amore A, Gianoglio B, Ghigo D, Peruzzi L, Porcellini MG, Bussolino F, Costamagna C, Cacace G, Picciotto G, Mazzucco G, Sena LM, Coppo R: A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. Kidney Int 47: 1507-1514, 1995
39. Reyes AA, Porras BH, Chasalow FI, Klahr S: L-Arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 45: 1346-1354, 1994
40. Waddington S, Cook HT, Reaveley D, Jansen A, Cattell V: L-Arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int 49: 1090-1096, 1996
41. Morrissey JJ, Ishidoya S, McCracken R, Klahr S: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 1: 2202-2212, 1996
42. Cook HT, Jansen A, Lewis S, Largen P, O'Donnell M, Reaveley D, Cattell V: Arginine metabolism in experimental glomerulonephritis: Interaction between nitric oxide synthase and arginase. Am J Physiol 267: F646-F653, 1994
43. Peters H, Noble NA: Dietary L-arginine in renal disease. Semin Nephrol 16: 567-575, 1996
44. Morrissey JJ, Klahr S: Effects of agmatine, an active metabolite of arginine metabolism, on the kidney. Nephrol Dial Transplant 11: 1217-1219, 1996
45. Narita I, Border WA, Ketteler M, Ruoslahti E, Noble NA: L-Arginine may mediate the therapeutic effects of low protein diets. Proc Natl Acad Sci USA 92: 4552-4556, 1995